UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
115.55
-1.58 (-1.35%)
Sep 2, 2025, 3:58 PM EDT
UCB SA Revenue
UCB SA had revenue of 3.49B EUR in the half year ending June 30, 2025, with 38.43% growth. This brings the company's revenue in the last twelve months to 6.85B, up 25.56% year-over-year. In the year 2024, UCB SA had annual revenue of 6.15B with 18.72% growth.
Revenue (ttm)
6.85B EUR
Revenue Growth
+25.56%
P/S Ratio
5.45
Revenue / Employee
730.22K EUR
Employees
9,378
Market Cap
43.81B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.15B | 970.00M | 18.72% |
Dec 31, 2023 | 5.18B | -265.00M | -4.87% |
Dec 31, 2022 | 5.45B | -330.00M | -5.71% |
Dec 31, 2021 | 5.78B | 430.00M | 8.04% |
Dec 31, 2020 | 5.35B | 434.00M | 8.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
UCB SA News
- 27 days ago - RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program - Benzinga
- 4 weeks ago - United Community Banks UCB Earnings Transcript - The Motley Fool
- 4 weeks ago - UCB SA (UCBJF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - UCB SA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - UCB SA reports 1H results - Seeking Alpha
- 5 weeks ago - United Community Banks, Inc. (UCB) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Biogen, UCB Take A Leap In Lupus With Promising Phase 3 Results - Benzinga
- 4 months ago - United Community Banks, Inc. (UCB) Q1 2025 Earnings Call Transcript - Seeking Alpha